News ArticleAbbott India Limited Announces Unaudited Q2 and Half Year Financial Results for September 30, 2026
Board of Directors approved results reviewed by statutory auditors Walker Chandiok & Co LLP on November 5, 2026
Abbott India Limited approved its unaudited financial results for the quarter and half year ended September 30, 2026, following a limited review by Walker Chandiok & Co LLP. The Board meeting was held on November 5, 2026, and the results cover Q2 and H1 of 2026. The company operates in Mumbai and holds the stock code 500488 on BSE.
Abbott India Limited
Financial Results
Abbott India Limited has approved its unaudited financial results for the quarter and half year ended September 30, 2026. The results were subjected to a limited review by Walker Chandiok & Co LLP, statutory auditors of the company.
The Board meeting took place on November 5, 2026, starting at 4:00 pm and concluding at 6:30 pm in Mumbai.
The announcement was made in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The financial results cover both the second quarter and the half-year period ending September 30, 2026.
Walker Chandiok & Co LLP conducted the limited review, certifying the unaudited results before approval by the board.
Highlights
- Unaudited financial results approved for Q2 and H1 ending September 30, 2026.
- Limited review performed by Walker Chandiok & Co LLP, statutory auditors.
- Board meeting held on November 5, 2026, from 4:00 pm to 6:30 pm.
- Compliance with SEBI Listing Regulations, specifically Regulation 33.
Key Data Snapshot
What happened
- Abbott India Limited's Board approved the unaudited financial results for Q2 and H1 of 2026.
- The financial results were subject to a limited review by the company’s statutory auditors.
- The Board meeting was conducted in Mumbai on November 5, 2026.
Regulatory and governance context
- The approval of financial results complies with Regulation 33 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
- Limited review report was issued as per regulatory requirements.
Highlights
- Unaudited financial results approved for Q2 and H1 ending September 30, 2026.
- Limited review performed by Walker Chandiok & Co LLP, statutory auditors.
- Board meeting held on November 5, 2026, from 4:00 pm to 6:30 pm.
- Compliance with SEBI Listing Regulations, specifically Regulation 33.
Disclosures
- SEBI Listing Obligations and Disclosure Requirements Regulations, 2015
- Regulation 30, Regulation 33
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Sansera Engineering Posts Rs 1,092.53 Million Profit in Q2 2026 After US$2 Million Lawsuit Settlement
Sansera Engineering Limited announced unaudited standalone results for Q2 and half year ended September 30, 2026, registering a net profit of Rs 1,092.53 million for the quarter and Rs 1,959.30 million for six months. The company settled a United States civil lawsuit by paying US$2 million during this period, recognized as an exceptional expense.
Read Full Story
Godfrey Phillips India Announces Q2 FY2027 Financial Results and Rs. 10 Per Share Interim Dividend
Godfrey Phillips India Limited approved its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company declared an interim dividend of 500% or Rs. 10 per equity share of Rs. 2 each for the fiscal year ending March 31, 2027.
Read Full Story
Rubicon Research Limited Reports ₹1,430.69 Million Net Profit for Half Year Ended September 30, 2026
Rubicon Research Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, reporting a net profit after tax of ₹1,430.69 million for the six-month period.
Read Full Story
